• Celebrate the holiday season with AcceGen’s highest discounts of the year. Merry Christmas and Happy New Year!

    Learn More
Primary Cells

Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

  • BSL

    1

  • 131
PBMCs are isolated from Acute Lymphoid Leukemia peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation, the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC3009

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Lymphoid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human acute lymphoid leukemia (ALL) peripheral blood mononuclear cells (PBMCs) (Newly Diagnosed/Untreated) are isolated from the peripheral blood of individuals diagnosed with ALL using gradient separation techniques and dilution with PBS. These cells are reported to exhibit potential resistance to apoptosis.Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated) In ALL PBMCs, the expression levels of initiator caspases-8 and -9, which play crucial roles in apoptosis, are increased compared to PBMCs from healthy individuals. Additionally, increased gene expression levels of the proapoptotic protein BAK have been detected in ALL PBMCs. These cells are available for study and analysis in the newly diagnosed and relapsed/refractory stages of ALL.

 

Why choose Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells from AcceGen?

Human acute lymphoid leukemia (ALL) peripheral blood mononuclear cells (PBMCs) from AcceGen are sterile, negative for bacteria, fungi, and mycoplasma. The production process adheres to rigorous quality control and is conducted by professional operators using standardized protocols. These measures ensure reliability and consistency in research and experimental studies involving ALL PBMCs.

View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • For research use only.

  • Peripheral blood mononuclear cells (PBMCs) are widely used in experimental studies. They are isolated from peripheral blood and are often employed to assess immune responses. PBMCs have wide application in many hot topics, for example, multi-omics analysis of PBMCs based on CITE-seq data, in vitro differentiation of PBMCs into cardiomyocytes or vascular-associated cells. Our products are ideal for establishing an in vitro PBMC differentiation system that allows you to combine molecular and cytological approaches to study the differentiation mechanisms of PBMCs.

Inquiring Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button